Quantcast
Channel: New-York – EEI-BIOTECHFINANCES
Viewing all articles
Browse latest Browse all 1030

CONMED Corporation to Present at the Deutsche Bank 42nd Annual Health Care Conference

$
0
0
Wednesday, April 19th 2017 at 8:01pm UTC

UTICA, N.Y.–(BUSINESS WIRE)– CONMED Corporation (NASDAQ: CNMD) today announced that Luke A.
Pomilio, Chief Financial Officer, and Patrick J. Beyer, President,
International, will present at the Deutsche Bank 42nd Annual
Health Care Conference at 12:50 p.m. ET on Wednesday, May 3, 2017 in
Boston, MA.

A live webcast of the presentation will be accessible through the
“Investors” section of the Company’s website at www.conmed.com
and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices
and equipment for minimally invasive procedures. The Company’s products
are used by surgeons and physicians in a variety of specialties,
including orthopedics, general surgery, gynecology, neurosurgery, and
gastroenterology. CONMED has a direct selling presence in 17 countries,
and international sales constitute approximately 50% of the Company’s
total sales. Headquartered in Utica, New York, the Company employs
approximately 3,300 people. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release contains forward-looking statements based on
certain assumptions and contingencies that involve risks and
uncertainties, which could cause actual results, performance, or trends
to differ materially from those expressed in the forward-looking
statements herein or in previous disclosures. For example, in addition
to general industry and economic conditions, factors that could cause
actual results to differ materially from those in the forward-looking
statements may include, but are not limited to, the risk factors
discussed in the Company’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2016.
 Any and all forward-looking
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995 and relate to the
Company’s performance on a going-forward basis. The Company believes
that all forward-looking statements made by it have a reasonable basis,
but there can be no assurance that management’s expectations, beliefs or
projections as expressed in the forward-looking statements will actually
occur or prove to be correct.

Contacts

CONMED Corporation
Luke A. Pomilio, 315-624-3202
Chief
Financial Officer

Source: CONMED Corporation

Cet article CONMED Corporation to Present at the Deutsche Bank 42nd
Annual Health Care Conference
est apparu en premier sur EEI-BIOTECHFINANCES.


Viewing all articles
Browse latest Browse all 1030

Trending Articles